← Back to screener

MACROGENICS INC MGNX

Rank #1804 · Nasdaq · $0.2B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
41.8
P/E
-16.8
P/B
1.07
ROE
-6.4%
Op. Margin
-286.4%
Debt Ratio
103%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E -16.8x, P/B 1.07x. Ranks in the top 48% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -6.4%. Ranks in the top 84% of the universe.

Safety ★★★☆☆
Good

Debt ratio 103%. Ranks in the top 40% of the universe.

Growth ★☆☆☆☆
Poor

Revenue decline of 61.3% year over year. Ranks in the top 98% of the universe.

Valuation is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2013$0.1B$0.0B$0.0B$-0.0B9.2-160
2014$0.1B$0.0B$0.0B$-0.0B12.9-268
2015$0.1B$0.0B$-0.0B$-0.0B0.6-639
2016$0.0B$-0.0B$-0.0B$0.1B-80.258
2017$0.1B$-0.0B$-0.0B$0.1B-20.035
2018$0.1B$-0.1B$-0.1B$0.3B-65.324
2019$0.2B$-0.0B$-0.0B$0.3B-14.033
2020$0.1B$-0.2B$-0.2B$0.3B-284.827
2021$0.1B$-0.2B$-0.2B$0.2B-276.034
2022$0.1B$-0.1B$-0.1B$0.2B-125.041
2023$0.1B$-0.2B$-0.2B$0.3B-261.947
2024$0.2B$-0.1B$-0.1B$0.2B-79.961
2025$0.1B$-0.2B$-0.0B$0.1B-286.4103

← See the full screener